• $31.8M
    Market Cap
  • -8.76%
    1-Year Change
  • Household & Personal Products
    Industry

Key Performance

More
  • Earnings Score: N/A
  • Momentum Score: 15
  • True Yield: N/A
  • Financial Health Score: N/A
TradeSmith Loading

Latest Research & News

Winner of My Stock-Picking Derby Sold Her Top Pick Too Soon

Heather Fisher won an annual stock-picking contest with a 287% average return on three picks, primarily due to an 849% gain in Aehr Test Systems. However, Fisher sold most of her AEHR shares before the dramatic climb, missing out on significant gains. The contest had 42 participants, with 18 beating the S&P 500's 23.3% return.

05/14/2026, 6:22 AM • Investing

United-Guardian Reports First Quarter Results

United-Guardian, Inc. reported Q1 2026 sales increased 15.8% to $2.87M and net income rose 45.9% to $0.18 per share, driven by 24% pharmaceutical sales growth (led by Renacidin) and 21% cosmetic ingredient sales growth. The company also recognized $303K in settlement income from a contract manufacturer. Management expects continued growth in 2026 from normalized distributor purchasing patterns and expanded market outreach.

05/08/2026, 9:00 AM • GlobeNewswire

United-Guardian Reports 2025 Financial Results

United-Guardian, Inc. (NASDAQ:UG) reported a 13% decline in net sales to $10.5M in 2025 from $12.2M in 2024, with net income falling to $2.1M ($0.46 per share) from $3.3M ($0.71 per share). The decline was driven by excess inventory at distributor Ashland Specialty Ingredients, decreased global demand particularly in China due to competition and tariffs, and reduced cosmetic ingredient sales. However, pharmaceutical sales increased 15% and medical lubricants rose 4%, with the company receiving pharmacy benefit manager approvals for Renacidin and entering new distribution agreements.

03/27/2026, 9:00 AM • GlobeNewswire

United-Guardian (UG) Q2 Sales Drop 16%

United-Guardian reported a 16.3% revenue decline in Q2 2025, primarily due to weak cosmetic ingredient sales from distributor inventory issues. Medical lubricants and pharmaceutical products showed growth, with management hopeful for cosmetic sales recovery in the second half of the year.

08/08/2025, 9:09 AM • The Motley Fool

Peers

  • BOF
    BRANCHOUT FOOD
    $3.68-1.60%
    Market Cap$52.8M
    1-Year Change+86.07%
  • IH
    iHuman Sp ADR-A
    $1.62-8.99%
    Market Cap$37.0M
    1-Year Change-20.77%
  • JZ
    JIANZHI SP ADS
    $0.34-51.57%
    Market Cap$33.7M
    1-Year Change-80.33%
  • JVA
    Coffee Holding
    $4.45-0.22%
    Market Cap$24.6M
    1-Year Change+12.23%
  • BNKK
    BONK
    $1.76-8.81%
    Market Cap$15.4M
    1-Year ChangeN/A
  • MTEX
    Mannatech
    $5.77+1.23%
    Market Cap$11.0M
    1-Year Change-46.23%
  • NCRA
    NOCERA
    $0.19+3.05%
    Market Cap$3.8M
    1-Year Change-83.43%
  • COOT
    AUSTRALIAN
    $0.61-1.58%
    Market CapN/A
    1-Year Change-24.25%
  • DSY
    BIG TREE CLOUD-A
    $1.86-2.11%
    Market CapN/A
    1-Year Change-92.52%

Statistics

More
Day Range
$6.87
$7.01
$6.99
1-Year Range
$5.62
$9.58
$6.99
Latest Close$6.99
Change
-$0.005 (-0.07%)
Volume2,829
Market Cap$31.8M
Shares Outstanding4.6M
P/E (TTM)13.47
Diluted EPS (TTM)$0.51
Enterprise Value$31.1M

Information as of 06/02/2026

Company Profile

UNITED GUARDIAN INC
https://u-g.com
$31.8M
Market Cap
$2.4M
Net Income
Sector: Consumer Defensive
Industry: Household & Personal Products
230 Marcus Boulevard, Hauppauge, NY, United States, 11788
631 273 0900

United-Guardian, Inc. develops, manufactures, sells, and markets specialty cosmetic ingredients, pharmaceutical products, medical lubricants, and sexual wellness ingredients in the United States and internationally. The company offers cosmetic ingredients, including LUBRAJEL, a line of multifunctional hydrogel formulations for personal care and medical products; B-122, a powdered lubricant used in the manufacture of certain cosmetics, such as pressed powders, eyeliners, and rouges, as well as some industrial products; ORCHID COMPLEX, an oil-based extract of orchids; and LUBRASIL II SB, a special formulation of Lubrajel in which silicone oil incorporates into a Lubrajel base. It also provides medical lubricant products for catheter lubrication, medical devices, condom lubrication, and oral care under the Lubrajel brand, including Lubrajel MG, Lubrajel MGL, Lubrajel RRCG, Lubrajel RR, Lubrajel RC, Lubrajel RA, Lubrajel Fluid, Lubrajel LC, Lubrajel BA, and Lubrajel FACO. In addition, the company offers pharmaceutical products comprising RENACIDIN, a prescription to prevent and to dissolve calcifications in urethral catheters; and CLORPACTIN WCS-90, a chlorine-based drug, which is a topical antimicrobial and is also used in urology. Further, it provides sexual wellness ingredient products, which are hydrogel formulations designed to offer sensory enhancement, lubrication, and moisturization, such as Natrajel NT, Natrajel MA, Natrajel ON, and Natrajel TE product lines. United-Guardian, Inc. was founded in 1942 and is based in Hauppauge, New York.

Key Executives

  • Donna Vigilante
  • Peter A. Hiltunen
  • Andrea J. Young
  • Denise Costrini

Current Ownership Distribution

  • Mutual Funds24.5M (53.10%)
  • Institutions19.0M (41.15%)
  • Insiders2.6M (5.75%)
  • Other0 (0.00%)